Business news, market intelligence, and global industry analysis.
The Latest

Dr. Reddy’s Laboratories launches Albendazole Tablets, USP in US

bySrinath
April 30, 2021
Total
0
Shares
0
0
0

Dr. Reddy’s Laboratories has launched Albendazole Tablets, USP, a generic version of GlaxoSmithKline’s Albenza Tablets, 200 mg, which are used for the treatment of a range of parasitic worm infestations.

Approved by the US Food and Drug Administration (FDA), Albenza brand and generic had sales of around $27 million MAT for the most recent twelve months ending in November 2020 as per IQVIA Health.

Dr. Reddy’s Laboratories said that its Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two.

Dr. Reddy’s Laboratories launches Albendazole Tablets, USP in US
Dr. Reddy’s Laboratories launches Albendazole Tablets, USP in US. Photo courtesy of Arichuvadi/Wikipedia.org.

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

See also  Amgen and Kyowa Kirin see breakthrough in rocatinlimab Phase 3 Trial, eyes on FDA path
Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Wuhan Coronavirus can be detected by Explify Respiratory test says IDby DNA

IDby DNA claims that its Explify Respiratory test can detect Wuhan Coronavirus apart from more than 900 viral, bacterial, fungal, and parasitic pathogens. According to the California-based metagenomics technology company, the Explify Respiratory test is a validated laboratory-developed test for respiratory pathogens like human coronaviruses. The Wuhan Coronavirus detection test is currently available at the […]
bypharmanewsdaily